LGR5‐Positive Colon Cancer Stem Cells Interconvert with Drug‐Resistant LGR5‐Negative cells and are Capable of Tumor Reconstitution-Reference-Cited by-同舟云学术

LGR5‐Positive Colon Cancer Stem Cells Interconvert with Drug‐Resistant LGR5‐Negative cells and are Capable of Tumor Reconstitution

Published:2012-11-27 Issue:12 Volume:30 Page:2631-2644
ISSN:1066-5099
Container-title:STEM CELLS
language:en
Short-container-title:STEM CELLS

Author:

Kobayashi Shinta¹²,Yamada‐Okabe Hisafumi²,Suzuki Masami²,Natori Osamu¹²,Kato Atsuhiko²,Matsubara Koichi¹²,Jau Chen Yu¹,Yamazaki Masaki²,Funahashi Shinichi³,Yoshida Kenji³,Hashimoto Eri⁴,Watanabe Yoshinori⁴,Mutoh Hironori⁴,Ashihara Motooki⁴,Kato Chie²,Watanabe Takeshi²,Yoshikubo Takashi²,Tamaoki Norikazu⁵,Ochiya Takahiro⁶,Kuroda Masahiko⁷,Levine Arnold J.⁸,Yamazaki Tatsumi³⁹

Affiliation:

1. PharmaLogicals Research Pte. Ltd., Singapore

2. Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd., Japan

3. Forerunner Pharma Research Co., Ltd., Japan

4. Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., Japan

5. Central Institute for Experimental Animals, Kawasaki, Japan

6. Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan

7. Department of Molecular Pathology, Tokyo Medical University, Tokyo, Japan

8. Institute for Advanced Study, Princeton, New Jersey, USA

9. Chugai Pharmaceutical Co., Ltd., Japan

Publisher

Oxford University Press (OUP)